X01179
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Lillicrap DP, et al. Variation of the non-factor VIII sequences detected by a probe from intron 22 of the factor VIII gene. Blood 75: 139-143, 1990. PubMed: 1967212
Taylor SA, et al. A BstXI polymorphism detected by the factor VIII genomic probe p482.6 (F8C). Nucleic Acids Res. 17: 6426, 1989. PubMed: 2570405
Suthers GK, et al. Physical mapping of new DNA probes near the fragile X mutation (FRAXA) by using a panel of cell lines. Am. J. Hum. Genet. 47: 187-195, 1990. PubMed: 2378346
Janco RL, et al. Improved efficacy of carrier assignment in hemophilia A using intragenic probes. Am. J. Hum. Genet. 39: A95, 1986.
Youssoufian H, et al. Characterization of five partial deletions of the factor VIII gene. Proc. Natl. Acad. Sci. USA 84: 3772-3776, 1987. PubMed: 3035554
Wion KL, et al. A new polymorphism in the factor VIII gene for prenatal diagnosis of hemophilia A. Nucleic Acids Res. 14: 4535-4542, 1986. PubMed: 3012474
<dfn id="cc4be"></dfn>